Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“ASCO 2025 Annual meeting is shaping up to be incredible!
With the amazing Scientific Chair Erika Hamilton and terrific Educational Chair Cardinale B. Smith curating the latest and greatest in oncology, it’s sure to be an event to remember. Can’t wait!
And… what an amazing crew of clinical trialists to hang out with.
So much fun to connect with these incredible minds at the ASCO headquarters as part of the Developmental Therapeutics group.
A few of these cool cutting-edge drugs in oncology today could be plenary talks 5 years from now! We can see the future.”
More posts featuring Vivek Subbiah.
